Preface |
|
iii | |
Contributors |
|
xi | |
|
A Conceptual History of Anxiety and Depression |
|
|
1 | (48) |
|
|
Epidemiology of Depression and Anxiety |
|
|
49 | (20) |
|
|
Comorbidity of Depression and Anxiety |
|
|
69 | (22) |
|
|
|
|
Anxiety, Depression, and Personality |
|
|
91 | (20) |
|
|
|
Is There a Common Etiology for Depression and Anxiety? |
|
|
111 | (16) |
|
|
|
Measurements of Depression and Anxiety Disorders |
|
|
127 | (24) |
|
|
|
Combining Psychotherapy and Pharmacotherapy for Depression and Anxiety |
|
|
151 | (14) |
|
|
|
|
165 | (24) |
|
|
|
|
189 | (18) |
|
|
Stress-Responsive Neurohormones in Depression and Anxiety |
|
|
207 | (22) |
|
|
|
Neuropeptide Alterations in Depression and Anxiety Disorders |
|
|
229 | (38) |
|
|
|
|
Immunology in Anxiety and Depression |
|
|
267 | (22) |
|
|
|
Brain Imaging in Depression and Anxiety |
|
|
289 | (42) |
|
|
|
|
Neurobiology of Anxiety and Depression |
|
|
331 | (18) |
|
|
|
Intracellular Signaling Transduction Dysregulation in Depression and Possible Future Targets for Antidepressant Therapy: Beyond the Serotonin Hypothesis |
|
|
349 | (38) |
|
|
|
|
|
Norepinephrine in Depression and Anxiety |
|
|
387 | (28) |
|
|
Benzodiazepines, Benzodiazepine Receptors, and Endogenous Ligands |
|
|
415 | (28) |
|
|
Antidepressants for the Treatment of Depression and Anxiety Disorders: Same Mechanism of Action? |
|
|
443 | (14) |
|
R. Hamish McAllister-Williams |
|
|
|
Studies on the Neurobiology of Depression |
|
|
457 | (48) |
|
|
|
Animal Models of Subtypes of Depression |
|
|
505 | (40) |
|
|
|
Pathogenesis of Depression: Reconsideration of Neurotransmitter Data by Depletion Paradigms |
|
|
545 | (16) |
|
|
Anastasios Konstantinidis |
|
|
Effects of Antidepressants on Specific Neurotransmitters: Are Such Effects Relevant to Therapeutic Actions? |
|
|
561 | (22) |
|
|
Pharmacotherapy of Depression: The Acute and Long-Term Perspective |
|
|
583 | (16) |
|
|
|
Pharmacotherapy of Bipolar Disorder |
|
|
599 | (16) |
|
|
|
Development of New Treatment Options for Depression |
|
|
615 | (14) |
|
|
|
The Depressed Patient: From Nonresponse to Complete Remission |
|
|
629 | (12) |
|
|
|
Pharmacogenetics of Mood Disorders: Is There a Future? |
|
|
641 | (16) |
|
|
|
|
Theories of the Etiology of Anxiety |
|
|
657 | (24) |
|
|
|
|
Animal Models of Anxiety and Anxiolytic Drug Action |
|
|
681 | (22) |
|
|
|
|
Provocation of Anxiety States in Humans and Its Possible Significance for the Pathogenesis of These Disorders |
|
|
703 | (30) |
|
|
|
|
|
Pharmacotherapy of Anxiety Disorders |
|
|
733 | (24) |
|
|
|
|
Pharmacotherapy of Mixed Anxiety/Depression Disorders |
|
|
757 | (22) |
|
|
|
|
|
|
|
New and Emerging Therapies for Anxiety |
|
|
779 | (10) |
|
|
|
Scales Used in Depression and Anxiety Research |
|
|
789 | (20) |
|
Index |
|
809 | |